Aclarion Inc. (NASDAQ: ACON)
$0.29
-0.0129 ( -4.31% ) 105.4K
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
Market Data
Open
$0.29
Previous close
$0.30
Volume
105.4K
Market cap
$2.40M
Day range
$0.29 - $0.31
52 week range
$0.27 - $11.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Aug 25, 2023 |
8-k | 8K-related | 14 | Aug 25, 2023 |
8-k | 8K-related | 14 | Aug 14, 2023 |
nt | Quarterly Reports | 1 | Aug 14, 2023 |
8-k | 8K-related | 13 | Aug 10, 2023 |
8-k | 8K-related | 14 | Jul 14, 2023 |
8-k | 8K-related | 13 | Jul 07, 2023 |
s-1/a | Registration statements | Jul 16, 2024 | |
s-1/a | Registration statements | Jul 16, 2024 | |
424b3 | Other | Jul 16, 2024 |